| |
Centre for Policy on Ageing | |
 | |
|
Alzheimer disease
— from molecular biology to therapy | | Author(s) | Robert Becker, Ezio Giacobini |
| Publisher | Birkhauser, Cambridge, MA, 1997 |
| Pages | 607 pp (Advances in Alzheimer Disease Therapy) |
| Source | Birkhauser Boston, 675 Massachusetts Avenue, Cambridge, MA 02139 USA. |
| Keywords | Dementia ; Biological sciences ; Therapeutics ; Drugs. |
| Annotation | This volume reviews potential treatments and clinical research findings which promise new treatments of Alzheimer disease. Clinical investigators report on each of the cholinesterase inhibitors that are in late stages of clinical development. Muscarinic and nicotinic agents, neuromodulators, nerve and other growth factors are also discussed. Also covered are: anti-oxidant and anti-inflammatory therapies; new drug developments; international harmonisation of drug development guidelines for dementia drugs; bioethics and law relevant to research into Alzheimer disease; development of rating instruments; behavioural treatments; and the activities of the Nancy and Ronald Regan Foundation. |
| Accession Number | CPA-970520220 B |
| Classmark | EA: Y7: LL: LLD |
Data © Centre for Policy on Ageing |
|
| ...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|